Connecting communities and clinics to increase early breast and cervical cancer screening in Kenya
Official title: An integrated community-clinic model of optimized implementation strategies to increase early detection of breast and cervical cancers in Kenya
Funded at Implenomics Llcs · NIH-11474012 · Data updated 2026-11-12
This project tries two community-plus-clinic programs to help women in Kenya get breast and cervical cancer screening and follow-up care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Implenomics Llcs NIH-funded |
| Lab location | 1 site (Marblehead, United States) |
| Project start | February 1, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $23,207 |
| NIH project number | 3R01CA269472-05S1 |
| Project ID | NIH-11474012 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are women eligible for breast or cervical cancer screening who live in the participating Kenyan communities and attend participating clinics.
✕Less likely to help
People who live outside the participating areas, men, or women who are already up-to-date on screening may not receive direct benefit from this program.
What this research studies
If you are a woman in a participating Kenyan community, community health volunteers will offer group education for you and family members and help link you to clinic services. Clinics in the same areas will get support to make screening easier and build team-based care so tests and results move more smoothly. Whole communities will be randomly assigned to one of two packages of these combined community and clinic strategies, and the study will track who gets screened, completes diagnostic tests, and starts treatment when needed. The project will also measure costs and implementation barriers to support wider rollout if one approach works well.
Why it matters
Potential benefit: If successful, more women could get timely screening and follow-up, leading to earlier detection of breast and cervical cancers and better chances for effective treatment.
How similar studies have gone: Community health worker outreach and clinic-strengthening approaches have shown promise in other low-resource settings, though testing combined packages in a randomized trial in Kenya is relatively new.
Where this research is happening
-
Implenomics Llcs
Marblehead, United States Active
Researchers
- Principal investigator: Subramanian, Sujha — Implenomics Llcs
- Study coordinator: Subramanian, Sujha
Related research
Other NIH-funded projects on the same topics.
-
Targeting tumor Lactobacillus iners to help cervical cancer patients
This grant seeks to understand how a specific bacteria, Lactobacillus iners, in cervical tumors affects treatment and outcomes, with the goal of improving therapy for women with cervical cancer.
-
Boosting early breast and cervical cancer screening in Kenyan communities
This project tests two combined community outreach and clinic-support programs to help women in Kenya get screened for breast and cervical cancer and receive timely follow-up.
-
Understanding bacteria in cervical cancer to improve treatment
This project looks at a specific bacteria found in cervical tumors to find new ways to make treatments work better for women with cervical cancer.
-
Improving early detection of breast and cervical cancers in Kenya
This study is working to help women in Kenya get better access to breast and cervical cancer screenings by connecting community resources and providing education, so they feel more informed and motivated to take care of their health.
-
Improving cervical cancer outcomes by targeting specific bacteria
This study is looking at how a certain bacteria called Lactobacillus iners, found in cervical tumors, might make cervical cancer harder to treat, and it hopes to find new ways to help women with advanced cervical cancer live longer and healthier lives.
-
Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer
This study tests whether a shorter, moderately intensified radiotherapy course after surgery is safe and effective for patients with cervical cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.